HomeCompareIQGLF vs MRK

IQGLF vs MRK: Dividend Comparison 2026

IQGLF yields 33.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IQGLF wins by $103.4K in total portfolio value
10 years
IQGLF
IQGLF
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full IQGLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IQGLF vs MRK

📍 IQGLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIQGLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IQGLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IQGLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IQGLF
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, IQGLF beats the other by $11,394.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IQGLF + MRK for your $10,000?

IQGLF: 50%MRK: 50%
100% MRK50/50100% IQGLF
Portfolio after 10yr
$108.5K
Annual income
$16,500.83/yr
Blended yield
15.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IQGLF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
8.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IQGLF buys
0
MRK buys
0
No recent congressional trades found for IQGLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIQGLFMRK
Forward yield33.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$160.1K$56.8K
Annual income after 10y$23,203.52$9,798.13
Total dividends collected$113.6K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: IQGLF vs MRK ($10,000, DRIP)

YearIQGLF PortfolioIQGLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,033$3,333.33$11,206$366.19+$2.8KIQGLF
2$19,387$4,371.75$12,650$502.35+$6.7KIQGLF
3$26,389$5,644.57$14,407$694.19+$12.0KIQGLF
4$35,417$7,180.46$16,585$967.82+$18.8KIQGLF
5$46,902$9,006.44$19,342$1,363.89+$27.6KIQGLF
6$61,333$11,146.93$22,913$1,947.19+$38.4KIQGLF
7$79,249$13,622.82$27,662$2,823.89+$51.6KIQGLF
8$101,247$16,450.69$34,159$4,173.35+$67.1KIQGLF
9$127,976$19,642.17$43,337$6,308.80+$84.6KIQGLF
10$160,138$23,203.52$56,776$9,798.13+$103.4KIQGLF

IQGLF vs MRK: Complete Analysis 2026

IQGLFStock

IQGeo Group plc develops geospatial software to the telecoms and utility network industries in the United Kingdom, Europe, the United States, Canada, Japan, and internationally. The company provides IQGeo Platform, which designs and manages complex and constantly evolving network assets; IQGeo Network Manager that plans, designs, and supports network lifecycle through construction and maintenance operations; IQGeo Workflow Manager software, which helps to control telecom and utility construction and maintenance activities; IQGeo Inspection and Survey software that provides a flexible mobile interface for field inspection teams; and IQGeo Network Revenue Optimizer software, which automatically produces multiple telecom construction route options for connecting commercial or residential premises. It also offers IQGeo development environment to implement applications that work in any modern web browser and on any mobile device, online or offline; IQGeo Fiber Planning software, which automatically generates a cost-optimized next-generation fiber network plan and design; IQGeo in the cloud, a cloud hosting of critical system infrastructure; IQGeo GIS integrations for data integration from virtually any application and geospatial data source; and IQGeo professional services. The company was formerly known as Ubisense Group Plc and changed its name to IQGeo Group plc in January 2019. IQGeo Group plc was founded in 2002 and is headquartered in Cambridge, the United Kingdom.

Full IQGLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IQGLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IQGLF vs SCHDIQGLF vs JEPIIQGLF vs OIQGLF vs KOIQGLF vs MAINIQGLF vs JNJIQGLF vs ABBVIQGLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.